This study also provides first evidence using a physiologically relevant in vivo model of CRC and raises the possibility that RIPK3-mediated responses might act to retard tumor growth in the intestine and that necroptosis might be tumor-suppressive in the intestine. Here, RIPK3 is linked to colorectal carcinoma.